Sandoz Gmbh
🇨🇷Costa Rica
Clinical Trials
22
Active:18
Completed:4
Trial Phases
2 Phases
Phase 1:12
Phase 3:4
Drug Approvals
147
CIMA_AEMPS:85
EMA:23
NMPA:13
+2 more agencies
Drug Approvals
Penicillin V Potassium Tablets
- Product Name
- 青霉素V钾片
- Approval Number
- 国药准字HJ20140783
- Approval Date
- Mar 20, 2024
NMPA
Penicillin V Potassium Tablets
- Product Name
- 青霉素V钾片
- Approval Number
- 国药准字HJ20140784
- Approval Date
- Mar 20, 2024
NMPA
Amoxicillin and Clavulanate Potassium Tablets
- Product Name
- 莱得怡
- Approval Number
- H20150630
- Approval Date
- May 28, 2020
NMPA
Losartan Potassium tablets/Losartanum kalicum tablets
- Product Name
- 氯沙坦钾片
- Approval Number
- 国药准字J20150076
- Approval Date
- May 21, 2020
NMPA
Losartan Potassium tablets/Losartanum kalicum tablets
- Product Name
- 氯沙坦钾片
- Approval Number
- H20140915
- Approval Date
- Apr 7, 2020
NMPA
Losartan Potassium tablets/Losartanum kalicum tablets
- Product Name
- 氯沙坦钾片
- Approval Number
- H20140914
- Approval Date
- Apr 7, 2020
NMPA
Penicillin V Potassium Tablets
- Product Name
- 青霉素V钾片
- Approval Number
- H20140783
- Approval Date
- May 6, 2019
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
12 (75.0%)Phase 3
4 (25.0%)No trials found
News
No news found